Global Therapeutic Nuclear Medicines Competitive Landscape Professional Research Report 2024

Global Therapeutic Nuclear Medicines Competitive Landscape Professional Research Report 2024

Research Summary

Therapeutic nuclear medicine involves the use of radioactive substances, known as radiopharmaceuticals, for the treatment of various medical conditions. Unlike diagnostic nuclear medicine, which focuses on imaging techniques to visualize internal structures and functions, therapeutic nuclear medicine employs radioactive materials to deliver targeted doses of radiation to specific tissues or organs to treat diseases. Common applications of therapeutic nuclear medicine include the treatment of certain types of cancer, such as thyroid cancer, lymphoma, and bone metastases, as well as non-cancerous conditions like hyperthyroidism and certain types of arthritis. Radiopharmaceuticals used in therapeutic nuclear medicine emit radiation that can selectively destroy or inhibit the growth of abnormal cells while minimizing damage to surrounding healthy tissues. This approach allows for precise and localized treatment, often with fewer side effects compared to traditional therapies. Therapeutic nuclear medicine plays a significant role in modern medicine, offering effective treatment options for a wide range of conditions.

According to DIResearch's in-depth investigation and research, the global Therapeutic Nuclear Medicines market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Therapeutic Nuclear Medicines include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus, Acrotech Biopharma., Progenics Pharmaceuticals, International Isotopes etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Therapeutic Nuclear Medicines. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Therapeutic Nuclear Medicines market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Therapeutic Nuclear Medicines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Therapeutic Nuclear Medicines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Therapeutic Nuclear Medicines Include:

Novartis AG

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Dongcheng

Lantheus

Acrotech Biopharma.

Progenics Pharmaceuticals

International Isotopes

Therapeutic Nuclear Medicines Product Segment Include:

Radium-223

Lutetium-177

Iodine-131

Other

Therapeutic Nuclear Medicines Product Application Include:

Thyroid

Bone Metastasis

Lymphoma

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Therapeutic Nuclear Medicines Industry PESTEL Analysis

Chapter 3: Global Therapeutic Nuclear Medicines Industry Porter’s Five Forces Analysis

Chapter 4: Global Therapeutic Nuclear Medicines Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Therapeutic Nuclear Medicines Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Therapeutic Nuclear Medicines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources